nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP3A5—Tamoxifen—pancreatic cancer	0.053	0.073	CbGbCtD
Ranitidine—CYP1A2—Dacarbazine—pancreatic cancer	0.0496	0.0683	CbGbCtD
Ranitidine—CYP3A5—Erlotinib—pancreatic cancer	0.045	0.0621	CbGbCtD
Ranitidine—CYP2C19—Tamoxifen—pancreatic cancer	0.0427	0.0589	CbGbCtD
Ranitidine—CYP3A5—Irinotecan—pancreatic cancer	0.0407	0.0561	CbGbCtD
Ranitidine—CYP1A2—Tamoxifen—pancreatic cancer	0.0394	0.0544	CbGbCtD
Ranitidine—ABCB1—Tamoxifen—pancreatic cancer	0.0345	0.0475	CbGbCtD
Ranitidine—CYP1A2—Erlotinib—pancreatic cancer	0.0335	0.0462	CbGbCtD
Ranitidine—CYP2D6—Tamoxifen—pancreatic cancer	0.0325	0.0448	CbGbCtD
Ranitidine—HRH2—gastric juice—pancreatic cancer	0.0306	0.774	CbGeAlD
Ranitidine—CYP3A5—Docetaxel—pancreatic cancer	0.0298	0.0411	CbGbCtD
Ranitidine—ABCB1—Gemcitabine—pancreatic cancer	0.0297	0.041	CbGbCtD
Ranitidine—CYP3A5—Sunitinib—pancreatic cancer	0.0297	0.0409	CbGbCtD
Ranitidine—ABCB1—Erlotinib—pancreatic cancer	0.0293	0.0404	CbGbCtD
Ranitidine—CYP1A2—Fluorouracil—pancreatic cancer	0.029	0.0401	CbGbCtD
Ranitidine—CYP2D6—Erlotinib—pancreatic cancer	0.0276	0.0381	CbGbCtD
Ranitidine—ABCB1—Irinotecan—pancreatic cancer	0.0265	0.0365	CbGbCtD
Ranitidine—CYP3A4—Tamoxifen—pancreatic cancer	0.0207	0.0285	CbGbCtD
Ranitidine—ABCB1—Docetaxel—pancreatic cancer	0.0194	0.0267	CbGbCtD
Ranitidine—ABCB1—Sunitinib—pancreatic cancer	0.0193	0.0266	CbGbCtD
Ranitidine—CYP3A4—Erlotinib—pancreatic cancer	0.0176	0.0242	CbGbCtD
Ranitidine—CYP3A4—Irinotecan—pancreatic cancer	0.0159	0.0219	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—pancreatic cancer	0.0145	0.0199	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—pancreatic cancer	0.0136	0.0188	CbGbCtD
Ranitidine—CYP3A4—Docetaxel—pancreatic cancer	0.0116	0.016	CbGbCtD
Ranitidine—CYP3A4—Sunitinib—pancreatic cancer	0.0116	0.016	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—pancreatic cancer	0.00866	0.0119	CbGbCtD
Ranitidine—HRH2—digestive system—pancreatic cancer	0.00186	0.0472	CbGeAlD
Ranitidine—CYP3A5—islet of Langerhans—pancreatic cancer	0.00121	0.0308	CbGeAlD
Ranitidine—CYP2C19—digestive system—pancreatic cancer	0.000926	0.0234	CbGeAlD
Ranitidine—CYP3A5—pancreas—pancreatic cancer	0.000854	0.0216	CbGeAlD
Ranitidine—CYP1A2—digestive system—pancreatic cancer	0.000756	0.0191	CbGeAlD
Ranitidine—CYP3A5—digestive system—pancreatic cancer	0.000729	0.0185	CbGeAlD
Ranitidine—ABCB1—islet of Langerhans—pancreatic cancer	0.000645	0.0163	CbGeAlD
Ranitidine—CYP3A4—digestive system—pancreatic cancer	0.000547	0.0139	CbGeAlD
Ranitidine—CYP2D6—digestive system—pancreatic cancer	0.000539	0.0136	CbGeAlD
Ranitidine—ABCB1—pancreas—pancreatic cancer	0.000454	0.0115	CbGeAlD
Ranitidine—Arthralgia—Gemcitabine—pancreatic cancer	0.000388	0.00185	CcSEcCtD
Ranitidine—Myalgia—Gemcitabine—pancreatic cancer	0.000388	0.00185	CcSEcCtD
Ranitidine—Chest pain—Gemcitabine—pancreatic cancer	0.000388	0.00185	CcSEcCtD
Ranitidine—ABCB1—digestive system—pancreatic cancer	0.000387	0.00981	CbGeAlD
Ranitidine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000386	0.00184	CcSEcCtD
Ranitidine—Confusional state—Irinotecan—pancreatic cancer	0.000385	0.00183	CcSEcCtD
Ranitidine—Discomfort—Gemcitabine—pancreatic cancer	0.000383	0.00183	CcSEcCtD
Ranitidine—Pruritus—Tamoxifen—pancreatic cancer	0.000383	0.00182	CcSEcCtD
Ranitidine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000382	0.00182	CcSEcCtD
Ranitidine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000382	0.00182	CcSEcCtD
Ranitidine—Chest pain—Fluorouracil—pancreatic cancer	0.000382	0.00182	CcSEcCtD
Ranitidine—Myalgia—Fluorouracil—pancreatic cancer	0.000382	0.00182	CcSEcCtD
Ranitidine—Pruritus—Erlotinib—pancreatic cancer	0.000379	0.00181	CcSEcCtD
Ranitidine—Discomfort—Fluorouracil—pancreatic cancer	0.000377	0.0018	CcSEcCtD
Ranitidine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000374	0.00178	CcSEcCtD
Ranitidine—Hepatic failure—Doxorubicin—pancreatic cancer	0.000373	0.00178	CcSEcCtD
Ranitidine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000372	0.00177	CcSEcCtD
Ranitidine—Hepatitis—Docetaxel—pancreatic cancer	0.000372	0.00177	CcSEcCtD
Ranitidine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00037	0.00176	CcSEcCtD
Ranitidine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000369	0.00176	CcSEcCtD
Ranitidine—Confusional state—Fluorouracil—pancreatic cancer	0.000369	0.00176	CcSEcCtD
Ranitidine—Abdominal pain—Sunitinib—pancreatic cancer	0.000366	0.00175	CcSEcCtD
Ranitidine—Body temperature increased—Sunitinib—pancreatic cancer	0.000366	0.00175	CcSEcCtD
Ranitidine—Diarrhoea—Erlotinib—pancreatic cancer	0.000366	0.00175	CcSEcCtD
Ranitidine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000366	0.00174	CcSEcCtD
Ranitidine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000364	0.00174	CcSEcCtD
Ranitidine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00036	0.00171	CcSEcCtD
Ranitidine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000358	0.00171	CcSEcCtD
Ranitidine—Dizziness—Tamoxifen—pancreatic cancer	0.000358	0.00171	CcSEcCtD
Ranitidine—Tachycardia—Fluorouracil—pancreatic cancer	0.000357	0.0017	CcSEcCtD
Ranitidine—Hypotension—Irinotecan—pancreatic cancer	0.000357	0.0017	CcSEcCtD
Ranitidine—Dizziness—Erlotinib—pancreatic cancer	0.000354	0.00169	CcSEcCtD
Ranitidine—Erythema multiforme—Docetaxel—pancreatic cancer	0.000351	0.00167	CcSEcCtD
Ranitidine—Hypotension—Gemcitabine—pancreatic cancer	0.000348	0.00166	CcSEcCtD
Ranitidine—Insomnia—Irinotecan—pancreatic cancer	0.000345	0.00165	CcSEcCtD
Ranitidine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000344	0.00164	CcSEcCtD
Ranitidine—Vomiting—Tamoxifen—pancreatic cancer	0.000344	0.00164	CcSEcCtD
Ranitidine—Hypotension—Fluorouracil—pancreatic cancer	0.000342	0.00163	CcSEcCtD
Ranitidine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000342	0.00163	CcSEcCtD
Ranitidine—Rash—Tamoxifen—pancreatic cancer	0.000341	0.00163	CcSEcCtD
Ranitidine—Dermatitis—Tamoxifen—pancreatic cancer	0.000341	0.00162	CcSEcCtD
Ranitidine—Vomiting—Erlotinib—pancreatic cancer	0.00034	0.00162	CcSEcCtD
Ranitidine—Dyspnoea—Irinotecan—pancreatic cancer	0.00034	0.00162	CcSEcCtD
Ranitidine—Somnolence—Irinotecan—pancreatic cancer	0.000339	0.00162	CcSEcCtD
Ranitidine—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000339	0.00162	CcSEcCtD
Ranitidine—Headache—Tamoxifen—pancreatic cancer	0.000339	0.00162	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000339	0.00162	CcSEcCtD
Ranitidine—Rash—Erlotinib—pancreatic cancer	0.000338	0.00161	CcSEcCtD
Ranitidine—Dermatitis—Erlotinib—pancreatic cancer	0.000337	0.00161	CcSEcCtD
Ranitidine—Insomnia—Gemcitabine—pancreatic cancer	0.000336	0.0016	CcSEcCtD
Ranitidine—Headache—Erlotinib—pancreatic cancer	0.000335	0.0016	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000333	0.00159	CcSEcCtD
Ranitidine—Arrhythmia—Docetaxel—pancreatic cancer	0.000332	0.00158	CcSEcCtD
Ranitidine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000332	0.00158	CcSEcCtD
Ranitidine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000331	0.00158	CcSEcCtD
Ranitidine—Insomnia—Fluorouracil—pancreatic cancer	0.000331	0.00158	CcSEcCtD
Ranitidine—Somnolence—Gemcitabine—pancreatic cancer	0.000331	0.00158	CcSEcCtD
Ranitidine—Alopecia—Docetaxel—pancreatic cancer	0.000328	0.00156	CcSEcCtD
Ranitidine—Pruritus—Sunitinib—pancreatic cancer	0.000328	0.00156	CcSEcCtD
Ranitidine—Breast disorder—Epirubicin—pancreatic cancer	0.000327	0.00156	CcSEcCtD
Ranitidine—Constipation—Irinotecan—pancreatic cancer	0.000327	0.00156	CcSEcCtD
Ranitidine—Pain—Irinotecan—pancreatic cancer	0.000327	0.00156	CcSEcCtD
Ranitidine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000326	0.00155	CcSEcCtD
Ranitidine—Somnolence—Fluorouracil—pancreatic cancer	0.000325	0.00155	CcSEcCtD
Ranitidine—Erythema—Docetaxel—pancreatic cancer	0.000323	0.00154	CcSEcCtD
Ranitidine—Nausea—Tamoxifen—pancreatic cancer	0.000322	0.00153	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00032	0.00152	CcSEcCtD
Ranitidine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000319	0.00152	CcSEcCtD
Ranitidine—Constipation—Gemcitabine—pancreatic cancer	0.000318	0.00152	CcSEcCtD
Ranitidine—Pain—Gemcitabine—pancreatic cancer	0.000318	0.00152	CcSEcCtD
Ranitidine—Nausea—Erlotinib—pancreatic cancer	0.000318	0.00152	CcSEcCtD
Ranitidine—Diarrhoea—Sunitinib—pancreatic cancer	0.000317	0.00151	CcSEcCtD
Ranitidine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000315	0.0015	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000314	0.0015	CcSEcCtD
Ranitidine—Dysphagia—Epirubicin—pancreatic cancer	0.000313	0.00149	CcSEcCtD
Ranitidine—Pain—Fluorouracil—pancreatic cancer	0.000313	0.00149	CcSEcCtD
Ranitidine—Eosinophilia—Epirubicin—pancreatic cancer	0.00031	0.00148	CcSEcCtD
Ranitidine—Pancreatitis—Epirubicin—pancreatic cancer	0.000307	0.00146	CcSEcCtD
Ranitidine—Dizziness—Sunitinib—pancreatic cancer	0.000307	0.00146	CcSEcCtD
Ranitidine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000307	0.00146	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000306	0.00146	CcSEcCtD
Ranitidine—Angina pectoris—Epirubicin—pancreatic cancer	0.000305	0.00145	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—pancreatic cancer	0.000303	0.00144	CcSEcCtD
Ranitidine—Body temperature increased—Irinotecan—pancreatic cancer	0.000302	0.00144	CcSEcCtD
Ranitidine—Abdominal pain—Irinotecan—pancreatic cancer	0.000302	0.00144	CcSEcCtD
Ranitidine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000301	0.00144	CcSEcCtD
Ranitidine—Anaemia—Docetaxel—pancreatic cancer	0.000299	0.00142	CcSEcCtD
Ranitidine—Pancytopenia—Epirubicin—pancreatic cancer	0.000297	0.00142	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000296	0.00141	CcSEcCtD
Ranitidine—Vomiting—Sunitinib—pancreatic cancer	0.000295	0.0014	CcSEcCtD
Ranitidine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000294	0.0014	CcSEcCtD
Ranitidine—Neutropenia—Epirubicin—pancreatic cancer	0.000293	0.0014	CcSEcCtD
Ranitidine—Rash—Sunitinib—pancreatic cancer	0.000292	0.00139	CcSEcCtD
Ranitidine—Dermatitis—Sunitinib—pancreatic cancer	0.000292	0.00139	CcSEcCtD
Ranitidine—Urticaria—Fluorouracil—pancreatic cancer	0.000291	0.00138	CcSEcCtD
Ranitidine—Headache—Sunitinib—pancreatic cancer	0.00029	0.00138	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—pancreatic cancer	0.00029	0.00138	CcSEcCtD
Ranitidine—Leukopenia—Docetaxel—pancreatic cancer	0.00029	0.00138	CcSEcCtD
Ranitidine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000289	0.00138	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000287	0.00137	CcSEcCtD
Ranitidine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000286	0.00136	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000284	0.00135	CcSEcCtD
Ranitidine—Weight decreased—Epirubicin—pancreatic cancer	0.000283	0.00135	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000282	0.00134	CcSEcCtD
Ranitidine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000281	0.00134	CcSEcCtD
Ranitidine—Pneumonia—Epirubicin—pancreatic cancer	0.000281	0.00134	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—pancreatic cancer	0.000275	0.00131	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—pancreatic cancer	0.000275	0.00131	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—pancreatic cancer	0.000275	0.00131	CcSEcCtD
Ranitidine—Nausea—Sunitinib—pancreatic cancer	0.000275	0.00131	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000275	0.00131	CcSEcCtD
Ranitidine—Jaundice—Epirubicin—pancreatic cancer	0.000272	0.0013	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—pancreatic cancer	0.000271	0.00129	CcSEcCtD
Ranitidine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000269	0.00128	CcSEcCtD
Ranitidine—Sweating—Epirubicin—pancreatic cancer	0.000268	0.00128	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—pancreatic cancer	0.000266	0.00127	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000264	0.00126	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000264	0.00126	CcSEcCtD
Ranitidine—Pruritus—Gemcitabine—pancreatic cancer	0.000263	0.00125	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—pancreatic cancer	0.000262	0.00125	CcSEcCtD
Ranitidine—Diarrhoea—Irinotecan—pancreatic cancer	0.000261	0.00125	CcSEcCtD
Ranitidine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000261	0.00124	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—pancreatic cancer	0.00026	0.00124	CcSEcCtD
Ranitidine—Pruritus—Fluorouracil—pancreatic cancer	0.000259	0.00123	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000258	0.00123	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—pancreatic cancer	0.000258	0.00123	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—pancreatic cancer	0.000255	0.00122	CcSEcCtD
Ranitidine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000255	0.00121	CcSEcCtD
Ranitidine—Dizziness—Irinotecan—pancreatic cancer	0.000253	0.0012	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—pancreatic cancer	0.000252	0.0012	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—pancreatic cancer	0.000251	0.00119	CcSEcCtD
Ranitidine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00025	0.00119	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—pancreatic cancer	0.000248	0.00118	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—pancreatic cancer	0.000247	0.00118	CcSEcCtD
Ranitidine—Vomiting—Irinotecan—pancreatic cancer	0.000243	0.00116	CcSEcCtD
Ranitidine—Dizziness—Fluorouracil—pancreatic cancer	0.000242	0.00115	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000241	0.00115	CcSEcCtD
Ranitidine—Rash—Irinotecan—pancreatic cancer	0.000241	0.00115	CcSEcCtD
Ranitidine—Dermatitis—Irinotecan—pancreatic cancer	0.000241	0.00115	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00024	0.00115	CcSEcCtD
Ranitidine—Headache—Irinotecan—pancreatic cancer	0.000239	0.00114	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—pancreatic cancer	0.000239	0.00114	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000237	0.00113	CcSEcCtD
Ranitidine—Vomiting—Gemcitabine—pancreatic cancer	0.000237	0.00113	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—pancreatic cancer	0.000236	0.00113	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—pancreatic cancer	0.000235	0.00112	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—pancreatic cancer	0.000235	0.00112	CcSEcCtD
Ranitidine—Rash—Gemcitabine—pancreatic cancer	0.000235	0.00112	CcSEcCtD
Ranitidine—Dermatitis—Gemcitabine—pancreatic cancer	0.000234	0.00112	CcSEcCtD
Ranitidine—Headache—Gemcitabine—pancreatic cancer	0.000233	0.00111	CcSEcCtD
Ranitidine—Vomiting—Fluorouracil—pancreatic cancer	0.000233	0.00111	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—pancreatic cancer	0.000232	0.00111	CcSEcCtD
Ranitidine—Rash—Fluorouracil—pancreatic cancer	0.000231	0.0011	CcSEcCtD
Ranitidine—Dermatitis—Fluorouracil—pancreatic cancer	0.00023	0.0011	CcSEcCtD
Ranitidine—Headache—Fluorouracil—pancreatic cancer	0.000229	0.00109	CcSEcCtD
Ranitidine—Nausea—Irinotecan—pancreatic cancer	0.000227	0.00108	CcSEcCtD
Ranitidine—Constipation—Docetaxel—pancreatic cancer	0.000226	0.00108	CcSEcCtD
Ranitidine—Pain—Docetaxel—pancreatic cancer	0.000226	0.00108	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—pancreatic cancer	0.000224	0.00107	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—pancreatic cancer	0.000221	0.00106	CcSEcCtD
Ranitidine—Nausea—Gemcitabine—pancreatic cancer	0.000221	0.00105	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000219	0.00104	CcSEcCtD
Ranitidine—Erythema—Epirubicin—pancreatic cancer	0.000218	0.00104	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000218	0.00104	CcSEcCtD
Ranitidine—Nausea—Fluorouracil—pancreatic cancer	0.000217	0.00104	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—pancreatic cancer	0.000209	0.000994	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—pancreatic cancer	0.000209	0.000994	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000207	0.000987	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—pancreatic cancer	0.000206	0.00098	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—pancreatic cancer	0.000205	0.000977	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000202	0.000965	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—pancreatic cancer	0.000202	0.000962	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—pancreatic cancer	0.000202	0.000961	CcSEcCtD
Ranitidine—Agitation—Epirubicin—pancreatic cancer	0.0002	0.000955	CcSEcCtD
Ranitidine—Malaise—Epirubicin—pancreatic cancer	0.000197	0.000938	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—pancreatic cancer	0.000196	0.000934	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—pancreatic cancer	0.000195	0.000931	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000194	0.000927	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—pancreatic cancer	0.00019	0.000907	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000187	0.000893	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—pancreatic cancer	0.000187	0.00089	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—pancreatic cancer	0.000187	0.000889	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—pancreatic cancer	0.000186	0.000885	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—pancreatic cancer	0.000186	0.000885	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—pancreatic cancer	0.000186	0.000885	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—pancreatic cancer	0.000186	0.000884	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—pancreatic cancer	0.000184	0.000875	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—pancreatic cancer	0.000182	0.000868	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—pancreatic cancer	0.000181	0.000864	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—pancreatic cancer	0.000181	0.000861	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—pancreatic cancer	0.000181	0.000861	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—pancreatic cancer	0.00018	0.000856	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000178	0.000849	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—pancreatic cancer	0.000175	0.000832	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000174	0.000831	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—pancreatic cancer	0.000174	0.000828	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000172	0.00082	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—pancreatic cancer	0.000172	0.000819	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—pancreatic cancer	0.000172	0.000819	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—pancreatic cancer	0.000172	0.000819	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—pancreatic cancer	0.00017	0.000809	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—pancreatic cancer	0.000168	0.0008	CcSEcCtD
Ranitidine—Rash—Docetaxel—pancreatic cancer	0.000166	0.000793	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—pancreatic cancer	0.000166	0.000793	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—pancreatic cancer	0.000166	0.000792	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—pancreatic cancer	0.000166	0.000792	CcSEcCtD
Ranitidine—Headache—Docetaxel—pancreatic cancer	0.000165	0.000788	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000165	0.000785	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000162	0.000773	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000161	0.000769	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—pancreatic cancer	0.000161	0.000767	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—pancreatic cancer	0.000161	0.000766	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000159	0.000759	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—pancreatic cancer	0.000159	0.000756	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—pancreatic cancer	0.000158	0.000754	CcSEcCtD
Ranitidine—Nausea—Docetaxel—pancreatic cancer	0.000157	0.000747	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—pancreatic cancer	0.000154	0.000734	CcSEcCtD
Ranitidine—Pain—Epirubicin—pancreatic cancer	0.000152	0.000726	CcSEcCtD
Ranitidine—Constipation—Epirubicin—pancreatic cancer	0.000152	0.000726	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00015	0.000715	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—pancreatic cancer	0.000149	0.00071	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000147	0.0007	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000147	0.000699	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—pancreatic cancer	0.000146	0.000698	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—pancreatic cancer	0.000141	0.000674	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—pancreatic cancer	0.000141	0.000671	CcSEcCtD
Ranitidine—Pain—Doxorubicin—pancreatic cancer	0.000141	0.000671	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—pancreatic cancer	0.000141	0.000671	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—pancreatic cancer	0.000141	0.000671	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000136	0.000647	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000131	0.000625	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—pancreatic cancer	0.000131	0.000624	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—pancreatic cancer	0.00013	0.000621	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00013	0.000621	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—pancreatic cancer	0.000126	0.0006	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—pancreatic cancer	0.000122	0.000581	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000121	0.000578	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—pancreatic cancer	0.000118	0.000561	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—pancreatic cancer	0.000117	0.000555	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—pancreatic cancer	0.000113	0.00054	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000113	0.000537	CcSEcCtD
Ranitidine—Rash—Epirubicin—pancreatic cancer	0.000112	0.000535	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—pancreatic cancer	0.000112	0.000535	CcSEcCtD
Ranitidine—Headache—Epirubicin—pancreatic cancer	0.000112	0.000532	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—pancreatic cancer	0.000109	0.000519	CcSEcCtD
Ranitidine—Nausea—Epirubicin—pancreatic cancer	0.000106	0.000504	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—pancreatic cancer	0.000105	0.000499	CcSEcCtD
Ranitidine—Rash—Doxorubicin—pancreatic cancer	0.000104	0.000495	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—pancreatic cancer	0.000104	0.000495	CcSEcCtD
Ranitidine—Headache—Doxorubicin—pancreatic cancer	0.000103	0.000492	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—pancreatic cancer	9.79e-05	0.000466	CcSEcCtD
Ranitidine—HRH2—Signaling by GPCR—AGTR1—pancreatic cancer	3.28e-05	0.00128	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	3.27e-05	0.00128	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	3.26e-05	0.00128	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	3.21e-05	0.00126	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	3.21e-05	0.00126	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SCT—pancreatic cancer	3.15e-05	0.00123	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HEY1—pancreatic cancer	3.15e-05	0.00123	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	3.06e-05	0.0012	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	3.06e-05	0.0012	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	3.03e-05	0.00119	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PRSS1—pancreatic cancer	3.02e-05	0.00118	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCK—pancreatic cancer	3.01e-05	0.00118	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CNR2—pancreatic cancer	2.93e-05	0.00115	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GLP1R—pancreatic cancer	2.93e-05	0.00115	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CXCL8—pancreatic cancer	2.93e-05	0.00115	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	2.9e-05	0.00114	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCKAR—pancreatic cancer	2.88e-05	0.00113	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—JAG2—pancreatic cancer	2.79e-05	0.00109	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MEN1—pancreatic cancer	2.75e-05	0.00108	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	2.66e-05	0.00104	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SHH—pancreatic cancer	2.63e-05	0.00103	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ARG2—pancreatic cancer	2.62e-05	0.00103	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOTCH4—pancreatic cancer	2.61e-05	0.00102	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IAPP—pancreatic cancer	2.59e-05	0.00102	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	2.58e-05	0.00101	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTHLH—pancreatic cancer	2.49e-05	0.000976	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTCH1—pancreatic cancer	2.49e-05	0.000976	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	2.48e-05	0.000973	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	2.47e-05	0.000967	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	2.36e-05	0.000926	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PRSS1—pancreatic cancer	2.34e-05	0.000919	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TYMP—pancreatic cancer	2.29e-05	0.000896	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SST—pancreatic cancer	2.28e-05	0.000892	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.25e-05	0.00088	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—JAG1—pancreatic cancer	2.23e-05	0.000873	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOTCH3—pancreatic cancer	2.22e-05	0.00087	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.15e-05	0.000844	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.13e-05	0.000837	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CNR1—pancreatic cancer	2.1e-05	0.000824	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.04e-05	0.000799	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ARG2—pancreatic cancer	2.03e-05	0.000796	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GCG—pancreatic cancer	2.03e-05	0.000795	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.97e-05	0.000774	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AGTR1—pancreatic cancer	1.94e-05	0.000759	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STK11—pancreatic cancer	1.91e-05	0.000748	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GLP1R—pancreatic cancer	1.84e-05	0.000722	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.82e-05	0.000711	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—DPYD—pancreatic cancer	1.81e-05	0.000711	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	1.81e-05	0.00071	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.79e-05	0.000703	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TYMP—pancreatic cancer	1.78e-05	0.000696	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PRSS1—pancreatic cancer	1.77e-05	0.000693	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—SLC2A2—pancreatic cancer	1.72e-05	0.000674	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.72e-05	0.000674	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.7e-05	0.000666	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.69e-05	0.00066	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SMAD4—pancreatic cancer	1.67e-05	0.000655	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.67e-05	0.000653	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.65e-05	0.000648	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.64e-05	0.000643	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HES1—pancreatic cancer	1.63e-05	0.00064	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.62e-05	0.000636	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.58e-05	0.00062	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.57e-05	0.000616	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.56e-05	0.000612	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ARG2—pancreatic cancer	1.53e-05	0.000601	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL8—pancreatic cancer	1.5e-05	0.000589	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.47e-05	0.000575	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.45e-05	0.000566	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.43e-05	0.000561	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TERT—pancreatic cancer	1.43e-05	0.00056	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.43e-05	0.00056	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.41e-05	0.000553	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.41e-05	0.000552	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.37e-05	0.000538	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HIF1A—pancreatic cancer	1.37e-05	0.000536	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TSC2—pancreatic cancer	1.36e-05	0.000535	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMP—pancreatic cancer	1.34e-05	0.000525	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.34e-05	0.000524	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—APOE—pancreatic cancer	1.34e-05	0.000523	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CD44—pancreatic cancer	1.33e-05	0.000522	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.32e-05	0.000516	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.31e-05	0.000514	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KDR—pancreatic cancer	1.31e-05	0.000513	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—HRAS—pancreatic cancer	1.3e-05	0.00051	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.29e-05	0.000504	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GCG—pancreatic cancer	1.28e-05	0.000501	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.26e-05	0.000495	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NFKBIA—pancreatic cancer	1.24e-05	0.000488	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOTCH1—pancreatic cancer	1.23e-05	0.000483	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.23e-05	0.00048	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.22e-05	0.00048	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.22e-05	0.000476	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CG—pancreatic cancer	1.2e-05	0.000472	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—NRAS—pancreatic cancer	1.2e-05	0.000472	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—STK11—pancreatic cancer	1.2e-05	0.000471	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGF—pancreatic cancer	1.19e-05	0.000467	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.13e-05	0.000444	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.12e-05	0.000438	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.11e-05	0.000434	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—pancreatic cancer	1.1e-05	0.00043	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.09e-05	0.000427	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.09e-05	0.000427	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.08e-05	0.000423	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.08e-05	0.000423	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.07e-05	0.000419	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—DPYD—pancreatic cancer	1.06e-05	0.000417	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CD—pancreatic cancer	1.06e-05	0.000415	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.05e-05	0.000411	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—KRAS—pancreatic cancer	1.04e-05	0.000406	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CD44—pancreatic cancer	1.04e-05	0.000406	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.03e-05	0.000405	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TYMS—pancreatic cancer	1.03e-05	0.000405	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.02e-05	0.000401	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.02e-05	0.000399	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.01e-05	0.000395	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—DPYD—pancreatic cancer	1e-05	0.000393	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GCG—pancreatic cancer	9.93e-06	0.000389	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.87e-06	0.000387	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CA—pancreatic cancer	9.53e-06	0.000373	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	9.51e-06	0.000373	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.45e-06	0.00037	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—STK11—pancreatic cancer	9.33e-06	0.000366	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CB—pancreatic cancer	9.23e-06	0.000362	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	9.12e-06	0.000358	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.99e-06	0.000352	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL8—pancreatic cancer	8.87e-06	0.000348	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.83e-06	0.000346	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—HRAS—pancreatic cancer	8.82e-06	0.000345	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	8.63e-06	0.000338	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AKT1—pancreatic cancer	8.57e-06	0.000336	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CASP3—pancreatic cancer	8.49e-06	0.000333	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—DPYD—pancreatic cancer	8.49e-06	0.000333	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—APOE—pancreatic cancer	8.41e-06	0.000329	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCND1—pancreatic cancer	8.27e-06	0.000324	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.26e-06	0.000324	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CTNNB1—pancreatic cancer	8.19e-06	0.000321	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	8.05e-06	0.000316	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TYMS—pancreatic cancer	8.03e-06	0.000315	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—pancreatic cancer	8.03e-06	0.000314	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CD44—pancreatic cancer	8e-06	0.000314	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—pancreatic cancer	7.98e-06	0.000313	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.97e-06	0.000312	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.84e-06	0.000307	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CD44—pancreatic cancer	7.81e-06	0.000306	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—pancreatic cancer	7.78e-06	0.000305	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.77e-06	0.000304	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.69e-06	0.000301	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GCG—pancreatic cancer	7.67e-06	0.000301	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	7.59e-06	0.000297	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GCG—pancreatic cancer	7.49e-06	0.000294	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SRC—pancreatic cancer	7.4e-06	0.00029	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CD44—pancreatic cancer	7.36e-06	0.000288	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PPARG—pancreatic cancer	7.32e-06	0.000287	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—STK11—pancreatic cancer	7.22e-06	0.000283	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—pancreatic cancer	7.21e-06	0.000282	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—pancreatic cancer	7.14e-06	0.00028	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NRAS—pancreatic cancer	7.12e-06	0.000279	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GCG—pancreatic cancer	7.06e-06	0.000277	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—STK11—pancreatic cancer	7.04e-06	0.000276	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.01e-06	0.000275	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.77e-06	0.000265	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	6.67e-06	0.000261	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.66e-06	0.000261	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—STK11—pancreatic cancer	6.64e-06	0.00026	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—pancreatic cancer	6.63e-06	0.00026	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TGFB1—pancreatic cancer	6.61e-06	0.000259	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.55e-06	0.000257	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—APOE—pancreatic cancer	6.53e-06	0.000256	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—pancreatic cancer	6.49e-06	0.000254	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CD44—pancreatic cancer	6.24e-06	0.000244	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.22e-06	0.000244	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMS—pancreatic cancer	6.21e-06	0.000243	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—pancreatic cancer	6.13e-06	0.00024	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.11e-06	0.000239	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMS—pancreatic cancer	6.06e-06	0.000237	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.05e-06	0.000237	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GCG—pancreatic cancer	5.98e-06	0.000234	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	5.89e-06	0.000231	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	5.81e-06	0.000228	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	5.76e-06	0.000226	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.71e-06	0.000224	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PPARG—pancreatic cancer	5.69e-06	0.000223	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—pancreatic cancer	5.63e-06	0.000221	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—STK11—pancreatic cancer	5.62e-06	0.00022	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—pancreatic cancer	5.45e-06	0.000213	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.28e-06	0.000207	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HRAS—pancreatic cancer	5.21e-06	0.000204	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	5.18e-06	0.000203	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—APOE—pancreatic cancer	5.05e-06	0.000198	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—pancreatic cancer	5.02e-06	0.000197	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—APOE—pancreatic cancer	4.93e-06	0.000193	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.84e-06	0.000189	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CD44—pancreatic cancer	4.81e-06	0.000189	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.78e-06	0.000187	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—APOE—pancreatic cancer	4.64e-06	0.000182	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GCG—pancreatic cancer	4.61e-06	0.000181	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—pancreatic cancer	4.6e-06	0.00018	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.56e-06	0.000179	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	4.52e-06	0.000177	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—pancreatic cancer	4.47e-06	0.000175	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	4.45e-06	0.000174	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PPARG—pancreatic cancer	4.4e-06	0.000172	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—STK11—pancreatic cancer	4.34e-06	0.00017	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PPARG—pancreatic cancer	4.29e-06	0.000168	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.19e-06	0.000164	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.04e-06	0.000158	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	4e-06	0.000157	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—APOE—pancreatic cancer	3.93e-06	0.000154	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.91e-06	0.000153	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.9e-06	0.000153	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.73e-06	0.000146	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.72e-06	0.000146	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.68e-06	0.000144	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.55e-06	0.000139	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	3.54e-06	0.000139	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.49e-06	0.000137	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.46e-06	0.000136	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.43e-06	0.000134	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	3.41e-06	0.000134	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—pancreatic cancer	3.38e-06	0.000132	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.21e-06	0.000126	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.18e-06	0.000125	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.12e-06	0.000122	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—APOE—pancreatic cancer	3.04e-06	0.000119	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—pancreatic cancer	3.02e-06	0.000118	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—pancreatic cancer	2.94e-06	0.000115	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—pancreatic cancer	2.89e-06	0.000113	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.77e-06	0.000109	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.75e-06	0.000108	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.74e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.72e-06	0.000107	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.69e-06	0.000106	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.64e-06	0.000104	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.41e-06	9.44e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.35e-06	9.21e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.25e-06	8.81e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.13e-06	8.34e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.1e-06	8.23e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.08e-06	8.15e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.08e-06	8.14e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.96e-06	7.67e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.81e-06	7.11e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.74e-06	6.81e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.7e-06	6.65e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.66e-06	6.5e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.6e-06	6.27e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.35e-06	5.31e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.28e-06	5.01e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.05e-06	4.1e-05	CbGpPWpGaD
